Back

DOACs to prevent VTE and to reduce the risk of stroke during hospitalization and during the first several months after hospital discharge.

29 August 2017 (13:00 - 13:20)
Organised by:
Congress Presentation Part of: New DOACs to prevent pulmonary embolism and stroke in heart failure and other hospitalized patients Antiarrhythmic drugs ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mr Mike Gibson

5 More presentations in this session

Presentation thumbnail
Welcome and introductions - New DOACs to prevent PE and stroke in HF and other hospitalized patients.
Doctor S. Goldhaber (Boston, US)
Presentation thumbnail
The critical unmet need of VTE prophylaxis in medically ill patients.
Doctor S. Goldhaber (Boston, US)
Presentation thumbnail
Antidotes for direct oral anticoagulants (DOACs).
Doctor A. Cohen (London, GB)
Presentation thumbnail
Case discussion - New DOACs to prevent PE and stroke in HF and other hospitalized patients.
Slides Video
Presentation thumbnail
Summary and concluding remarks - New DOACs to prevent PE and stroke in HF and other hospitalized patients.
Doctor S. Goldhaber (Boston, US)

Access the full session

Session thumbnail
New DOACs to prevent pulmonary embolism and stroke in heart failure and other hospitalized patients

The Event

Event poster

ESC Congress 2017

29 August 2017 13:00 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources